Spectral Medical Inc.
TSX: EDT.TO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Toronto Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Christopher Seto
- Employees
- 29
- Headquarters
- Toronto, Canada
- IPO year
- 1996
- Market cap
- CA$419.6M
- Website
- https://www.spectraldx.com
Loading EDT…
Loading profile data…Frequently asked questions about EDT
What does Spectral Medical Inc. (EDT.TO) do?
Spectral Medical Inc., together with its subsidiaries, focuses on the development and commercialization of products for the treatment of septic shock and renal disease in North America. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxi...
Where does EDT.TO trade?
Spectral Medical Inc. (EDT.TO) trades on the Toronto Stock Exchange.
What sector is EDT.TO in?
Spectral Medical Inc. (EDT.TO) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Spectral Medical Inc.?
Christopher Seto is the chief executive officer of Spectral Medical Inc. (EDT.TO).
Where is Spectral Medical Inc. headquartered?
Spectral Medical Inc. is headquartered in Canada.
Does EDT.TO pay a dividend?
Spectral Medical Inc. (EDT.TO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did EDT.TO go public?
Spectral Medical Inc. (EDT.TO) completed its initial public offering in 1996.